Peer-reviewed trials from China have reported 100% technical and clinical success in robot-assisted cerebral angiography, ...

Patients with adrenal insufficiency had significant improvements in bone and metabolic markers on a once-daily, low-dose ...

Medical societies are urging the adoption of ALARA+, the new cath lab standard of "as low and as light as reasonably ...

Karyopharm Therapeutics (NASDAQ:KPTI) reported top-line results from its phase III SENTRY trial evaluating selinexor in ...

Treatment-naive patients with early RA and hand-dominant joint involvement are more likely to achieve better disease activity ...

The U.S. Department of State (DOS) published a final rule amending Diversity Immigrant Visa Program (DV Program) requirements ...

With thoracic oncology in the middle of a combinatorial revolution—EGFR-targeted doublets and triplets, a maturing ...

Postmenopausal women may have a powerful new edge in the battle against weight gain. A Mayo Clinic study found that those using menopausal hormone therapy while taking the obesity drug tirzepatide ...

TG4050, Transgene’s first INTV, demonstrated durable clinical outcomes in resected head and neck squamous cell carcinoma (HNSCC) and potential to prevent cancer relapse "Together with the updated ...

The difference between productivity illusion and productivity advantage lies in how they are deployed in a structured, ...

A randomized trial finds weekly extended-release buprenorphine yields neonatal outcomes comparable to sublingual treatment.

Pooled evidence from 2 randomized trials and 6 observational cohorts suggests posttransplant gilteritinib maintenance may ...